Even in this current era of web app dominance, there are still many situations where local, standalone tools are ...
Transaction values AMPERA at approximately $900 million on a pre-money equity basis.Transaction expected to provide up to approximately $357 million in gross cash proceeds, including more than $30 mil ...
Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing novel biologic therapeutic candidates, today announced updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results